Nanalysis Scientific Corp.
NSCIF
$0.12
$0.00-1.63%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.20% | 51.32% | -167.15% | 74.28% | 48.88% |
| Total Depreciation and Amortization | -68.98% | -72.11% | 128.32% | -58.86% | -6.84% |
| Total Amortization of Deferred Charges | -- | -- | -74.42% | -- | -- |
| Total Other Non-Cash Items | -63.57% | -42.79% | 682.41% | -78.83% | 492.77% |
| Change in Net Operating Assets | -202.99% | 22.03% | 62.74% | -36.21% | 269.55% |
| Cash from Operations | -246.99% | 71.90% | 140.65% | 76.54% | 130.75% |
| Capital Expenditure | -8,885.71% | -3.58% | 100.00% | 2.22% | 99.55% |
| Sale of Property, Plant, and Equipment | 83.59% | -- | 11,128.57% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 30.76% | 4.99% | 69.05% | 55.35% | 75.71% |
| Cash from Investing | 21.05% | 5.90% | 80.61% | 68.55% | 79.50% |
| Total Debt Issued | -- | -- | -56.18% | -56.91% | -- |
| Total Debt Repaid | 85.75% | 35.28% | -290.31% | 69.30% | 73.16% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -1,900.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.66% | 40.37% | 77.39% | 4.55% | -355.00% |
| Cash from Financing | 234.81% | -5,415.15% | -90.21% | 83.80% | -112.91% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.79% | -167.21% | 318.89% | 75.88% | -117.44% |